Physician profile
Shaina E Barr
NPI 1336628718
$1,288.91
in general payments reported to CMS, 2019-2025
14 companies · $83.24 in 2025
The $83.24 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $469 · 2023: $261 · 2024: $158 · 2025: $83.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $547.42 | 2021-2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $125.00 | 2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $98.47 | 2021-2023 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.28 | 2021-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $77.72 | 2021-2022 | |
| Abbvie INC. | $63.08 | 2024 | |
| Janssen Pharmaceuticals, INC | $60.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.54 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.97 | 2024 | Trintellix |
| Glaxosmithkline, LLC. | $34.77 | 2021 | |
| Hologic Sales and Service, LLC | $25.47 | 2022 | |
| Sumitomo Pharma America, INC. | $22.92 | 2023 | Gemtesa |
| Medtronic, INC. | $21.57 | 2025 | Closurefast |
| Bausch Health US, LLC | $18.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaina Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.